Martin-Immanuel Bittner

Co-founder & CEO - Arctoris

Martin-Immanuel Bittner MD DPhil FRSA FRSB FIBMS is the Chief Executive Officer of Arctoris, a biotech company combining automated wet lab operations and machine learning for accelerated small molecule discovery. Martin graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford, where he co-founded Arctoris. He has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organizations, including EACR, AACR, and ESTRO. Martin is an elected member of the Young Academy of the German National Academy of Sciences and of Sigma Xi, and has been named Innovator of the Year in Biotechnology 2020 by SBR